Shopping Cart 0
Cart Subtotal
USD 0

DiaSorin SpA (DIA) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company's products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin SpA (DIA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

DiaSorin SpA, Medical Equipment, Deal Details 10

Asset Purchase 10

DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11

Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For USD 10 Million 13

Partnerships 14

Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14

AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15

DiaSorin Enters into Agreement with Tecan 16

DiaSorin Enters into Agreement with QIAGEN 17

DiaSorin Enters into Agreement with Beckman Coulter 18

DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19

Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20

DiaSorin Forms Joint Venture With Trivitron Healthcare 21

Asset Transactions 22

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22

DiaSorin SpA-Key Competitors 24

DiaSorin SpA-Key Employees 25

DiaSorin SpA-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 28

Financial Announcements 28

Aug 02, 2018: The Board of Directors approves the results for the first half of 2018 28

May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 32

Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 35

Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 36

May 08, 2017: Diasorin Group Reports Growth In Revenues And Profitability In The First Quarter 2017, Generating A Relevant Free Cash Flow 39

Mar 08, 2017: Net Profit And Cash Generation Reached Record Highs In 2016, Driven By Growth In Revenues And Profitability 41

Product News 44

Jun 12, 2018: Diasorin Introduces Primer Pair Reagents For Use In Molecular Testing: Anaplasma Phagocytophilum, Ehrlichia And Babesia 44

Jun 12, 2018: DiaSorin Molecular Introduces Primer Pair Reagents for A. phagocytophilum, Ehrlichia and Babesia 45

Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 46

Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 47

Other Significant Developments 48

Jun 26, 2017: Diasorin Presents Its 2017-2019 Industrial Plan 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

DiaSorin SpA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

DiaSorin SpA, Medical Equipment, Key Facts, 2017 2

DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

DiaSorin SpA, Deals By Market, 2012 to YTD 2018 8

DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11

Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For USD 10 Million 13

Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14

AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15

DiaSorin Enters into Agreement with Tecan 16

DiaSorin Enters into Agreement with QIAGEN 17

DiaSorin Enters into Agreement with Beckman Coulter 18

DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19

Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20

DiaSorin Forms Joint Venture With Trivitron Healthcare 21

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22

DiaSorin SpA, Key Competitors 24

DiaSorin SpA, Key Employees 25

DiaSorin SpA, Other Locations 26

DiaSorin SpA, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

DiaSorin SpA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.